Trademark applications and grants for Sillajen Biotherapeutics Inc. Sillajen Biotherapeutics Inc has 8 trademark applications. The latest application filed is for "SILLAJEN BIOTHERAPEUTICS"
Patent Application | Date |
---|---|
ONCOLYTIC VACCINIA VIRUS CANCER THERAPY 20210322578 - 17/200725 Kirn; David | 2021-10-21 |
ONCOLYTIC VACCINIA VIRUS CANCER THERAPY 20200009269 - 16/577966 Kirn; David | 2020-01-09 |
METHODS AND COMPOSITIONS FOR PRODUCTION OF VACCINA VIRUS 20190169578 - 16/270585 KIRN; David ;   et al. | 2019-06-06 |
ONCOLYTIC VACCINIA VIRUS CANCER THERAPY 20180256751 - 15/892265 KIRN; David | 2018-09-13 |
GENERATION OF ANTIBODIES TO TUMOR ANTIGENS AND GENERATION OF TUMOR SPECIFIC COMPLEMENT DEPENDENT CYTOTOXICITY BY ADMINISTRATION OF ONCOLYTIC VACCINIA VIRUS 20180214538 - 15/892247 KIRN; David ;   et al. | 2018-08-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.